株探米国株
日本語 英語
エドガーで原本を確認する
0001386301 false 0001386301 2023-09-13 2023-09-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report:

(Date of earliest event reported)

 

September 13, 2023

 

 

 

Research Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other Jurisdiction of Incorporation)

 

1-39256

  11-3797644
(Commission File Number)   (IRS Employer Identification No.)

 

N/A

(Address of Principal Executive Offices and zip code)

 

(310) 477-0354

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class Trading Symbol(s) Name of each Exchange on which  registered
Common stock, $0.001 par value RSSS

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company     ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

 

 

 

 


 

Item 2.02. Results of Operations and Financial Condition.

 

On September 13, 2023, the Registrant announced its financial results for the fourth quarter and fiscal year ended June 30, 2023. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits.

 

  Exhibit
Number
Description
99.1 Press Release issued September 13, 2023 entitled “Research Solutions Announces Fiscal Fourth Quarter and Full Year 2023 Results”.
104 Cover Page Interactive Data File (embedded as Inline XBRL document)

 

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  RESEARCH SOLUTIONS, INC.
   
   
Date: September 13, 2023 By: /s/ William Nurthen
    William Nurthen
    Chief Financial Officer

 

 

 

EX-99.1 2 tm2326104d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

 

Research Solutions Announces Fiscal Fourth Quarter and Full Year 2023 Results

 

Reports Full-Year GAAP Net Income, Record Adjusted EBITDA and 28% Increase in Platform Revenue

 

HENDERSON, Nev., September 13, 2023 — Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, reported financial results for its fiscal fourth quarter and full year ended June 30, 2023.

 

Fiscal Fourth Quarter 2023 Summary

 

Total revenue increased 16% to $10.0 million
Platform revenue up 22% to $2.3 million; Annual recurring revenue up 19% to $9.4 million
Gross profit up 19% to the prior-year quarter; Total gross margin improved 110 basis points to 39.4%
Net income of $375,746 or one cent per diluted share, compared to a net loss of ($438,267) or one cent per share in the prior-year quarter
Adjusted EBITDA of $825,087 compared to ($121,327) in the same period a year ago
Cash flow from operations of $1.5 million compared to slightly negative cash flow in the prior-year quarter

 

Full-Year Fiscal 2023 Summary

 

Total revenue increased 14% to $37.7 million
Platform revenue of $8.7 million, a 28% increase, with a 14% increase in total deployments to 835
Total gross margin increased 250 basis points to 39.0%
Net income of $0.6 million, or $0.02 per diluted share, compared to a net loss of $1.6 million or ($0.06) per share in the prior year
Adjusted EBITDA of $2.0 million compared to ($0.4 million) in the previous year
Cash flow from operations of $3.4 million, compared to ($0.4 million) in the previous year

 

 


 

Items Subsequent to End of Fiscal 2023

 

Acquired ResoluteAI, a developer of advanced search and discovery tools
Engaged Jeremy Murphy as an advisor and observer to the Board of Directors

 

“Fiscal year 2023 was an exciting year for our business. Our results represent the significant progress made across our organization, highlighted by our highest annual organic revenue growth in more than a decade and first year of GAAP profitability since fiscal 2015,” said Roy W. Olivier, President and CEO of Research Solutions. “Our customers continue to recognize the greater efficiency and cost savings offered through our Article Galaxy platform and our recent acquisition of ResoluteAI expands these offerings and capabilities, providing us with meaningful cross-selling opportunities. While we continue to see headwinds in the platform business, we are optimistic about our fiscal year 2024 and look to continue to grow the business organically as well as through strategic M&A.”

 

Fiscal Fourth Quarter 2023 Results

 

Total revenue increased 16% to $10.0 million, compared to $8.6 million in the same year-ago quarter.

 

Platform subscription revenue increased 22% to $2.3 million compared to approximately $1.9 million in the year-ago quarter. The increase was primarily due to an increase in upsell activity within our existing customer base and an increase in the total number of paid Platform deployments, including 20 added in the quarter. The quarter ended with annual recurring revenue of $9.4 million, up 4% sequentially and 19% year-over-year (see the company's definition of annual recurring revenue below).

 

Transaction revenue was up 15%, increasing to $7.7 million, compared to $6.7 million in the fourth quarter of fiscal 2022. Transaction customers count for the quarter was 1,404, compared to 1,213 customers in the prior year quarter (see the company's definition of active customer accounts and transactions below).

 

Total gross margin improved 110 basis points from the prior-year quarter to 39.4%. The increase was primarily driven by a continued revenue mix shift to the higher-margin Platform business.

 

Total operating expenses were approximately $3.7 million, a $62,000 decrease from the fourth quarter of 2022. The decrease was primarily due to lower sales and marketing expenses.

 

Net income in the fourth quarter was $376,000, or one cent per diluted share, compared to a net loss of ($438,000), or two cents per share, in the prior-year quarter. Adjusted EBITDA was $825,000, compared to ($121,000) in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

 

Full-Year Fiscal 2023 Results

 

Total revenue increased 14% to $37.7 million, compared to $32.9 million in fiscal 2022.

 

Platform subscription revenue was $8.7 million, a 28% increase over the prior year. The increase was due to upselling current platform customers and an increase in the total number of paid Platform deployments.

 

 


 

Transaction revenue was $29.0 million, an 11% increase compared to the previous year. The increase is primarily due to organic growth and also the acquisition of certain customer contracts from FIZ Karlsruhe which became effective in the third quarter of fiscal 2023.

 

Total gross margin improved 250 basis points over the prior year to 39.0%. The increase was primarily driven by a continued revenue mix shift to the higher-margin Platform business.

 

Total operating expenses were $14.5 million compared to $13.7 million in the prior year. The increase was primarily due to higher stock compensation expense related to the transition to a new program that the Company views as better aligned with shareholders’ interests.

 

Net income for fiscal year 2023 was $572,000, or $0.02 per diluted share. Net loss in fiscal 2022 was $1.6 million, or ($0.06) per share. Adjusted EBITDA for fiscal 2023 was a positive $2.0 million, compared to a negative $374,000 in the prior year (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

 

Cash and cash equivalents on June 30, 2023, amounted to $13.5 million compared to $10.6 million as of June 30, 2022. There were no outstanding borrowings under the company's $2.5 million revolving line of credit and the company had no long-term liabilities or other debt.

 

 

Conference Call

 

Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.

 

Date: Wednesday, September 13, 2023

Time: 5:00 p.m. ET (2:00 p.m. PT)

Dial-in number: 1-412-317-5180

Conference ID: 10182138

 

The conference call will be broadcast live and available for replay until October 13, 2023, by dialing 1-412-317-6671 and using the replay ID 10182138, and via the investor relations section of the company's website at http://researchsolutions.investorroom.com/.

 

 


 

Fiscal Fourth Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter

 

    Quarter Ended June 30,        
    2023     2022     Change     % Change  
Revenue:                        
Platforms   $ 2,303,375     $ 1,886,845     $ 416,530       22.1 %
Transactions   $ 7,656,342     $ 6,675,164       981,178       14.7 %
Total Revenue     9,959,717       8,562,009       1,397,708       16.3 %
                                 
Gross Profit:                                
Platforms     2,028,265       1,646,631       381,634       23.2 %
Transactions     1,892,278       1,636,511       255,767       15.6 %
Total Gross Profit     3,920,543       3,283,142       637,401       19.4 %
                                 
Gross profit as a % of revenue:                                
Platforms     88.1 %     87.3 %     0.8 %        
Transactions     24.7 %     24.5 %     0.2 %        
Total Gross Profit     39.4 %     38.3 %     1.0 %        
                                 
Operating Expenses:                                
Sales and marketing     455,030       691,368       (236,338 )     -34.2 %
Technology and product development     991,093       1,049,430       (58,337 )     -5.6 %
General and administrative     1,649,333       1,663,671       (14,339 )     -0.9 %
Depreciation and amortization     22,163       5,507       16,656       302.5 %
Stock-based compensation     585,384       225,501       359,883       159.6 %
Foreign currency translation loss     (37,743 )     91,279       (129,022 )     NM  
Total Operating Expenses     3,665,260       3,726,756       (61,497 )     -1.7 %
Income (loss) from operations     255,283       (443,614 )     698,897       157.5 %
                                 
Other Income (Expenses):                                
Other income (expense)     120,522       6,377       114,145       NM  
Provision for income taxes     (59 )     (1,030 )     971       -94.3 %
Total Other Income (Expenses):     120,463       5,347       115,116       NM  
Net income (loss)   $ 375,746     $ (438,267 )     814,013       185.7 %
Adjusted EBITDA   $ 825,087     $ (121,327 )   $ 946,414       NM  

 

    Quarter Ended June 30,        
    2023     2022     Change     % Change  
Platforms:                        
ARR (Annual recurring revenue):                                
Beginning of Period   $ 9,107,681     $ 7,348,847     $ 1,758,834       23.9 %
Incremental ARR     336,449       573,341       (236,892 )     -41.3 %
End of Period   $ 9,444,130     $ 7,922,188     $ 1,521,942       19.2 %
                                 
Deployments:                                
Beginning of Period     815       680       135       19.9 %
Incremental Deployments     20       53       (33 )     -62.3 %
End of Period     835       733       102       13.9 %
                                 
ASP (Average sales price):                                
Beginning of Period   $ 11,175     $ 10,807     $ 368       3.4 %
End of Period   $ 11,310     $ 10,808     $ 502       4.6 %
                                 
Transaction Customers:                                
Corporate customers     1,090       920       170       18.5 %
Academic customers     314       293       21       7.2 %
Total customers     1,404       1,213       191       15.7 %

 

 


 

Fiscal Full Year Financial and Operational Summary Tables vs. Prior-Year

 

    Twelve Months Ended June 30,        
    2023     2022     Change     % Change  
Revenue:                        
Platforms   $ 8,683,246     $ 6,787,772     $ 1,895,474       27.9 %
Transactions   $ 29,020,206     $ 26,146,380       2,873,826       11.0 %
Total Revenue     37,703,452       32,934,152       4,769,300       14.5 %
                                 
Gross Profit:                                
Platforms     7,655,960       5,851,183       1,804,777       30.8 %
Transactions     7,044,931       6,168,491       876,440       14.2 %
Total Gross Profit     14,700,891       12,019,674       2,681,217       22.3 %
                                 
Gross profit as a % of revenue:                                
Platforms     88.2 %     86.2 %     2.0 %        
Transactions     24.3 %     23.6 %     0.7 %        
Total Gross Profit     39.0 %     36.5 %     2.5 %        
                                 
Operating Expenses:                                
Sales and marketing     2,285,478       2,276,172       9,306       0.4 %
Technology and product development     3,742,192       3,711,085       31,107       0.8 %
General and administrative     6,654,012       6,406,400       247,612       3.9 %
Depreciation and amortization     52,649       17,651       34,998       198.3 %
Stock-based compensation     1,849,906       1,096,384       753,522       68.7 %
Foreign currency translation loss     (121,953 )     143,898       (265,851 )     NM  
Total Operating Expenses     14,462,284       13,651,590       810,694       5.9 %
Income (loss) from operations     238,608       (1,631,916 )     1,870,523       114.6 %
                                 
Other Income (Expenses):                                
Other income (expense)     338,617       7,154       331,463       NM  
Provision for income taxes     (5,602 )     (7,622 )     2,020       -26.5 %
Total Other Income (Expenses):     333,015       (468 )     333,483       NM  
Net income (loss)   $ 571,623     $ (1,632,384 )     2,204,006       135.0 %
Adjusted EBITDA   $ 2,019,210     $ (373,983 )   $ 2,393,192       NM  

 

    Twelve Months Ended June 30,        
    2023     2022     Change     % Change  
Platforms:                        
ARR (Annual recurring revenue):                                
Beginning of Period   $ 7,922,188     $ 5,880,179     $ 2,042,009       34.7 %
Incremental ARR     1,521,942       2,042,009       (520,067 )     -25.5 %
End of Period   $ 9,444,130     $ 7,922,188     $ 1,521,942       19.2 %
                                 
Deployments:                                
Beginning of Period     733       553       180       32.5 %
Incremental Deployments     102       180       (78 )     -43.3 %
End of Period     835       733       102       13.9 %
                                 
ASP (Average sales price):                                
Beginning of Period   $ 10,808     $ 10,633     $ 175       1.6 %
End of Period   $ 11,310     $ 10,808     $ 502       4.6 %
                                 
Transaction Customers:                                
Corporate customers     1,012       886       126       14.2 %
Academic customers     304       299       5       1.6 %
Total customers     1,316       1,185       131       11.1 %

 

 


 

Active Customer Accounts, Transactions and Annual Recurring Revenue

 

The company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

 

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

 

The company defines annual recurring revenue as the value of contracted Platform subscription recurring revenue normalized to a one-year period.

 

Use of Non-GAAP Measure – Adjusted EBITDA

 

Research Solutions’ management evaluates and makes operating decisions using various financial metrics. In addition to the company’s GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the company’s operating results.

 

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense), foreign currency transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, gain on sale of discontinued operations, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):

 

    Quarter Ended June 30,        
    2023     2022     Change     % Change  
Net Income (loss)   $ 375,746     $ (438,267 )   $ 814,013       185.7 %
Add (deduct):                                
Other income (expense)     (120,522 )     (6,377 )     (114,145 )     NM  
Foreign currency translation loss     (37,743 )     91,279       (129,022 )     -141.3 %
Provision for income taxes     59       1,030       (971 )     -94.3 %
Depreciation and amortization     22,163       5,507       16,656       302.5 %
Stock-based compensation     585,384       225,501       359,883       159.6 %
Adjusted EBITDA   $ 825,087     $ (121,327 )   $ 946,414       NM  

 

    Twelve Months Ended June 30,        
    2023     2022     Change     % Change  
Net Income (loss)   $ 571,623     $ (1,632,384 )   $ 2,204,006       135.0 %
Add (deduct):                     -          
Other income (expense)     (338,617 )     (7,154 )     (331,463 )     NM  
Foreign currency translation loss     (121,953 )     143,898       (265,851 )     -184.7 %
Provision for income taxes     5,602       7,622       (2,020 )     -26.5 %
Depreciation and amortization     52,649       17,651       34,998       198.3 %
Stock-based compensation     1,849,906       1,096,384       753,522       68.7 %
Adjusted EBITDA   $ 2,019,210     $ (373,983 )   $ 2,393,192       NM  

 

 


 

About Research Solutions

 

Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of obtaining, managing, and creating intellectual property. Founded in 2006 as Reprints Desk, the company was a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, the company's SaaS research platform, to streamline access to the latest scientific research and data with 24/7 customer support. For more information and details, please visitwww.researchsolutions.com and www.reprintsdesk.com

 

Important Cautions Regarding Forward-Looking Statements

 

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding improved product offerings and cross-selling opportunities, , management’s optimistic outlook for fiscal 2024, and the Company’s prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission. 

 

 


 

Research Solutions, Inc. and Subsidiaries

Consolidated Balance Sheets

 

    June 30,     June 30,  
    2023     2022  
Assets                
Current assets:                
Cash and cash equivalents   $ 13,545,333     $ 10,603,175  
Accounts receivable, net of allowance of $85,015 and $94,144, respectively     6,153,063       5,251,545  
Prepaid expenses and other current assets     400,340       276,026  
Prepaid royalties     1,202,678       846,652  
Total current assets     21,301,414       16,977,398  
                 
Other assets:                
Property and equipment, net of accumulated depreciation of $881,908 and $840,996, respectively     70,193       47,985  
Intangible assets, net of accumulated amortization of $747,355 and $723,036, respectively     462,068        
Deposits and other assets     1,052       893  
Total assets   $ 21,834,727     $ 17,026,276  
                 
Liabilities and Stockholders’ Equity                
Current liabilities:                
Accounts payable and accrued expenses   $ 8,079,516     $ 6,604,032  
Deferred revenue     6,424,724       5,538,526  
Total current liabilities     14,504,240       12,142,558  
                 
Commitments and contingencies                
                 
Stockholders’ equity:                
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding            
Common stock; $0.001 par value; 100,000,000 shares authorized; 29,487,508 and 27,075,648 shares issued and outstanding, respectively     29,487       27,076  
Additional paid-in capital     29,941,873       28,072,855  
Accumulated deficit     (22,522,649 )     (23,094,272 )
Accumulated other comprehensive loss     (118,224 )     (121,941 )
Total stockholders’ equity     7,330,487       4,883,718  
Total liabilities and stockholders’ equity   $ 21,834,727     $ 17,026,276  

 

 


 

Research Solutions, Inc. and Subsidiaries

Consolidated Statements of Operations and Other Comprehensive Loss

 

    Years Ended  
    June 30,  
    2023     2022  
Revenue:                
Platforms   $ 8,683,246     $ 6,787,772  
Transactions     29,020,206       26,146,380  
Total revenue     37,703,452       32,934,152  
                 
Cost of revenue:                
Platforms     1,027,286       936,589  
Transactions     21,975,275       19,977,889  
Total cost of revenue     23,002,561       20,914,478  
Gross profit     14,700,891       12,019,674  
                 
Operating expenses:                
Selling, general and administrative     14,409,634       13,633,939  
Depreciation and amortization     52,649       17,651  
Total operating expenses     14,462,283       13,651,590  
                 
Income (loss) from operations     238,608       (1,631,916 )
                 
Other income     338,617       7,154  
                 
Income (loss) from operations before provision for income taxes     577,225       (1,624,762 )
Provision for income taxes     (5,602 )     (7,622 )
                 
Net income (loss)     571,623       (1,632,384 )
                 
Other comprehensive income (loss):                
Foreign currency translation     3,717       (2,364 )
Comprehensive income (loss)   $ 575,340     $ (1,634,748 )
                 
Basic income (loss) per common share:                
Net income (loss) per share   $ 0.02     $ (0.06 )
Weighted average common shares outstanding     26,860,761       26,422,295  
                 
Diluted income (loss) per common share:                
Net income (loss) per share   $ 0.02     $ (0.06 )
Weighted average common shares outstanding     29,139,759       26,422,295  

 

 


 

Research Solutions, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

 

    Years Ended  
    June 30,  
    2023     2022  
Cash flow from operating activities:                
Net income (loss)   $ 571,623     $ (1,632,384 )
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities:                
Depreciation and amortization     52,649       17,651  
Fair value of vested stock options     375,189       470,615  
Fair value of vested restricted common stock     1,418,718       557,496  
Fair value of vested unrestricted common stock     68,272        
Modification cost of stock options     56,000        
Changes in operating assets and liabilities:                
Accounts receivable     (901,518 )     (534,092 )
Prepaid expenses and other current assets     (124,314 )     (5,774 )
Prepaid royalties     (356,026 )     58,269  
Accounts payable and accrued expenses     1,337,056       (83,156 )
Deferred revenue     886,198       734,175  
Net cash provided by (used in) operating activities     3,383,847       (417,200 )
                 
Cash flow from investing activities:                
Purchase of property and equipment     (47,209 )     (44,288 )
Payment for non-refundable deposit for asset acquisition     (297,450 )      
Net cash used in investing activities     (344,659 )     (44,288 )
                 
Cash flow from financing activities:                
Proceeds from the exercise of stock options     57,500       97,688  
Proceeds from the exercise of warrants           59,500  
Common stock repurchase     (104,250 )     (93,918 )
Payment of contingent acquisition consideration     (50,509 )      
Net cash provided by (used in) financing activities     (97,259 )     63,270  
                 
Effect of exchange rate changes     229       (2,944 )
Net increase (decrease) in cash and cash equivalents     2,942,158       (401,162 )
Cash and cash equivalents, beginning of period     10,603,175       11,004,337  
Cash and cash equivalents, end of period   $ 13,545,333     $ 10,603,175  
                 
Supplemental disclosures of cash flow information:                
Cash paid for income taxes   $ 5,602     $ 7,622  
                 
Non-cash investing and financing activities:                
Contingent consideration accrual on asset acquisition   $ 138,428     $  

 

 

Contact

Steven Hooser or John Beisler

Three Part Advisors

(214) 872-2710

 

shooser@threepa.com; jbeisler@threepa.com

 

# # #